Phases précoces tumeurs solides MK-1454-001 (STING) Study of MK-1454 Alone or in Combination With Pembrolizumab in Participants With Advanced/Metastatic Solid Tumors or Lymphomas (MK-1454-001) Paris EMANUELA ROMANO
Phases précoces tumeurs solides MOVIE M17 (GEP-15) A Phase I/II Basket Trial Evaluating a Combination of Metronomic Oral Vinorelbine Plus Anti-PD-L1/Anti-CTLA4 ImmunothErapy in Patients With Advanced Solid Tumour Paris CHRISTOPHE LE TOURNEAU
Phases précoces tumeurs solides CC-95775-ST-001 A PHASE 1B DOSE ESCALATION, MULTICENTER, OPEN-LABEL STUDY TO EVALUATE THE SAFETY, TOLERABILITY, PHARMACOKINETIC AND PHARMACODYNAMIC OF CC-95775 IN SUBJECTS WITH ADVANCED SOLID TUMORS AND RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA Paris CHRISTOPHE LE TOURNEAU
Recherches "plusieurs pathologies" MS1000070-176 An Open-Label, Multicenter Follow-up Study to Collect Long-term Data on Participants From Multiple Avelumab (MSB0010718C) Clinical Studies Paris
Phases précoces tumeurs solides M19-037 A Phase 1, Multicenter, Open-Label Study to Determine the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of Combinations of ABBV-927 With ABBV-368, Budigalimab (ABBV-181) and/or Chemotherapy in Subjects With Locally Advanced or Metastatic Solid Tumors Paris CHRISTOPHE LE TOURNEAU
Phases précoces tumeurs solides XL 184_021 Study of Cabozantinib in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid Tumors Paris
Sein métastatique triple négatif SYNERGY A Phase I/II Study of Paclitaxel Plus Carboplatin and Durvalumab (MEDI4736) With or Without Oleclumab (MEDI9447) for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple-negative Breast Cancer. Paris
Phases précoces tumeurs solides INCB 86550-102 A Phase 1 Study Exploring the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of INCB086550 in Participants With Advanced Solid Tumors Paris CHRISTOPHE LE TOURNEAU
Phases précoces tumeurs solides EMBER (J2J-MC-JZLA) EMBER: A Phase 1a/1b Study of LY3484356 Administered as Monotherapy and in Combination With Anticancer Therapies for Patients With ER+ Locally Advanced or Metastatic Breast Cancer and Other Select Non-Breast Cancers. Paris JEAN-YVES PIERGA
Phases précoces tumeurs solides MCLA-158-CL01 Phase 1 Dose Finding Study Evaluating the Bispecific Antibody MCLA-158 in Metastatic Colorectal Cancer and Other Advanced Solid Tumors. Paris CHRISTOPHE LE TOURNEAU